SCHEMBL6288517

SCHEMBL6288517

CCOC(=O)c1nn(C)c2nc(-c3cccc(F)c3)cc(NNc3ccc(Cl)cc3)c12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.42
KDM4E B2RXH2 7/20 0.42
HPGD P15428 6/20 0.42
SMN1; SMN2 Q16637 4/20 0.42
MEN1 O00255 2/20 0.42
CYP1A2 P05177 2/20 0.42
CYP2C9 P11712 2/20 0.42
CYP2C19 P33261 2/20 0.42
KMT2A Q03164 2/20 0.42
NPSR1 Q6W5P4 2/20 0.42
CYP3A4 P08684 1/20 0.42
HSD17B10 Q99714 2/20 0.41
MAPK1 P28482 1/20 0.41
CLK1 P49759 1/20 0.41
UBE2N P61088 1/20 0.41
CSNK1D P48730 1/20 0.40
JAK2 O60674 1/20 0.40
JAK3 P52333 1/20 0.40
TRPM8 Q7Z2W7 1/20 0.39
MAPT P10636 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6288516 0.72 S1PR2 (0.39) ALDH1A1KDM4EHPGDMEN1CYP1A2
SCHEMBL19437829 0.70 CSNK1D (0.47) ALDH1A1KDM4EHPGDSMN1; SMN2MEN1
SCHEMBL14640582 0.69 MAPT (0.58) ALDH1A1KDM4EHPGDSMN1; SMN2MEN1
SCHEMBL18355564 0.69 JAK2 (0.49) ALDH1A1KDM4EHPGDSMN1; SMN2MEN1
SCHEMBL19438100 0.69 CSNK1D (0.46) ALDH1A1KDM4EHPGDSMN1; SMN2MEN1
SCHEMBL3342312 0.66 ALDH1A1 (0.54) ALDH1A1KDM4EHPGDSMN1; SMN2MEN1
SCHEMBL20028187 0.66 JAK2 (0.55) ALDH1A1KDM4EHPGDSMN1; SMN2MEN1
SCHEMBL2017634 0.66 CYP1A2 (0.55) ALDH1A1KDM4EHPGDCYP1A2CYP2C9
SCHEMBL9585774 0.65 JMJD6 (0.50) ALDH1A1KDM4EHPGDSMN1; SMN2MEN1
SCHEMBL1765415 0.65 CHRNA7 (0.64) SMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6900223-B2 Dihydrodipyrazolopyridinone inhibitors of B7-1 WYETH (US) 2005-05-31 US disclosed
US-20040044024-A1 Dihydrodipyrazolopyridinone inhibitors of B7-1 WYETH (US) 2004-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040044024-A1 Dihydrodipyrazolopyridinone inhibitors of B7-1 CD274, PDCD1, PDCD1LG2 ALDH1A1 53/4885KDM4E 799/4885HPGD 760/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.